Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mateo Farina Nunez"'
Autor:
Stephanie Stock, Martin Hellmich, Jörg-Christian Tonn, Lukas Radbruch, Niklas Thon, Claudia Bausewein, Stefanie Hamacher, Heidrun Golla, Charlotte Nettekoven, Berend Feddersen, Oliver Schnell, Christopher Böhlke, Gerhild Becker, Roman Rolke, Hans Clusmann, Ulrich Herrlinger, Hartmut Vatter, Erdem Güresir, Dirk Müller, Daniele Civello, Irini Papachristou, Raymond Voltz, Roland Goldbrunner, Imke Bronger, Kerstin Dederichs, Hildegard Cavelius, Sonja Hiddemann, Norbert Krumm, Christina Thamm, Daniel Delev, Marita Kumschlies, Manuela Langheimer, Chuh-Hyoun Na, Christiane Landwehr, Niklas Schäfer, Christina Schaub, Claudia Stratmann, Kirsten Hüning, Birgit Jaspers, Michaela Hesse, Isabel Franke, Melanie Joshi, Simone Matte, Lena Dreher, Gina Fürtjes, Sophia Kochs, Moritz Lenschow, Patrick Melich, Catharina Schröter, Bianca-Ioana Blaß, Debora Cipriani, Dieter Henrik Heiland, Pamela Heiland, Nadja Jarc, Nicole Koch, Marcia Regina Machein, Nicolas Neidert, Mateo Farina Nunez, Jolanda Daniuk, Bianca Lauble, Tina Meer, Saskia Opitz, Birgit Haberland, Eva Lehmann, Karla Steinberger, Sabine Streitwieser, Christoph Barth, Stefanie Lietke, Christiane Zimmerer
Publikováno v:
BMJ Open, Vol 10, Iss 1 (2020)
Introduction Randomised controlled trials (RCTs) have shown a positive effect of early integration of palliative care (EIPC) in various advanced cancer entities regarding patients’ quality of life (QoL), survival, mood, caregiver burden and redu
Externí odkaz:
https://doaj.org/article/7f97c7a1972842d0b59e87a92be06584
Autor:
Dieter H. Heiland, Robin Ohle, Debora Cipriani, Pamela Franco, Daniel Delev, Simon P. Behriger, Elias Kellner, Gergana Petrova, Nicolas Neidert, Irina Mader, Mateo Fariña Nuñez, Horst Urbach, Roman Sankowski, Jürgen Beck, Oliver Schnell
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Oligodendroglioma (ODG) are CNS resistant tumors characterized by their unique molecular signature, namely a combined deletion of 1p and 19q simultaneously to an IDH1/2 mutation. These tumors have a more favorable clinical outcome
Externí odkaz:
https://doaj.org/article/8fd799d9bbda4b3a99dbe6f84861fdf8